Clinical Trial Update: Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 study investigates whether an NMDA receptor antagonist can modulate the effects of transcranial direct current stimulation on sensory discrimi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: University of Ottawa | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: UNKNOWN